Publications by authors named "James Bading"

Claim this Profile
T
The Role of HER2 PET in Treatment of Breast Cancer.
James R Bading, Joanne E Mortimer

J Nucl Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Molecular Imaging in Precision Oncology.
James R Bading, Joanne E Mortimer

J Nucl Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yttrium-90 anti-CD25 BEAM conditioning for autologous hematopoietic cell transplantation in Peripheral T-cell lymphoma.
Jasmine Zain, Ni-Chun Tsai, Joycelynne Palmer, Jennifer Simpson, Vikram Adhikarla, James R Bading

Blood Adv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine for Metastatic Breast Cancer: A Pilot Study.
Joanne E Mortimer, James R Bading, Paul H Frankel, Mary I Carroll, Yuan Yuan

J Nucl Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma.
Alex F Herrera, Joycelynne Palmer, Vikram Adhikarla, Dave Yamauchi, Erasmus K Poku, James Bading

Blood Adv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical PET Imaging of NTSR-1-Positive Tumors with Cu- and Ga-DOTA-Neurotensin Analogs and Therapy with an Ac-DOTA-Neurotensin Analog.
Daneng Li, Megan Minnix, Rebecca Allen, James Bading, Junie Chea

Cancer Biother Radiopharm· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing Malignancies.
David Akhavan, Paul Yazaki, Dave Yamauchi, Jennifer Simpson, Paul H Frankel, James Bading

Cancer Biother Radiopharm· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Uptake of Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer.
Joanne E Mortimer, James R Bading, Jinha M Park, Paul H Frankel, Mary I Carroll

J Nucl Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic PET Imaging of Mammary Microcalcifications Using Cu-DOTA-Alendronate in a Rat Model of Breast Cancer.
Bradley J Ahrens, Lin Li, Alexandra K Ciminera, Junie Chea, Erasmus Poku, James R Bading

J Nucl Med· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptations of Arginine's Intestinal-Renal Axis in Cachectic Tumor-Bearing Rats.
Nikki Buijs, Mechteld A R Vermeulen, Viola B Weeda, James R Bading, Alexander P J Houdijk

Nutr Cancer· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma.
Christine E Brown, Behnam Badie, Michael E Barish, Lihong Weng, Julie R Ostberg, James R Bading

Clin Cancer Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET.
Joanne E Mortimer, James R Bading, David M Colcher, Peter S Conti, Paul H Frankel

J Nucl Med· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor quantification in clinical positron emission tomography.
Bing Bai, James Bading, Peter S Conti

Theranostics· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative, simultaneous PET/MRI for intratumoral imaging with an MRI-compatible PET scanner.
Thomas S C Ng, James R Bading, Ryan Park, Hargun Sohi, Daniel Procissi

J Nucl Med· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetic analysis of 18F-FLT PET in lung tumors.
James R Bading

J Nucl Med· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo imaging of transplanted islets with 64Cu-DO3A-VS-Cys40-Exendin-4 by targeting GLP-1 receptor.
Zhanhong Wu, Ivan Todorov, Lin Li, James R Bading, Zibo Li

Bioconjug Chem· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site-specific conjugation of monodispersed DOTA-PEGn to a thiolated diabody reveals the effect of increasing peg size on kidney clearance and tumor uptake with improved 64-copper PET imaging.
Lin Li, Desiree Crow, Fabio Turatti, James R Bading, Anne-Line Anderson

Bioconjug Chem· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monodispersed DOTA-PEG-conjugated anti-TAG-72 diabody has low kidney uptake and high tumor-to-blood ratios resulting in improved 64Cu PET.
Lin Li, Fabio Turatti, Desiree Crow, James R Bading, Anne-Line Anderson

J Nucl Med· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative serial imaging of an 124I anti-CEA monoclonal antibody in tumor-bearing mice.
James R Bading, Magnus Hörling, Lawrence E Williams, David Colcher, Andrew Raubitschek

Cancer Biother Radiopharm· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging of cell proliferation: status and prospects.
James R Bading, Anthony F Shields

J Nucl Med· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biodistribution and tumor imaging of an anti-CEA single-chain antibody-albumin fusion protein.
Paul J Yazaki, Thewodros Kassa, Chia-wei Cheung, Desiree M Crow, Mark A Sherman, James R Bading

Nucl Med Biol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodies.
Lin Li, James Bading, Paul J Yazaki, Amitkumar H Ahuja, Desiree Crow

Bioconjug Chem· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo measurement of cell proliferation in canine brain tumor using C-11-labeled FMAU and PET.
Peter S Conti, James R Bading, Peter P Mouton, Jonathan M Links, Mian M Alauddin

Nucl Med Biol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence.
Chun-Peng Liao, Chen Zhong, Gohar Saribekyan, James Bading, Ryan Park

Cancer Res· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smad3 deficiency promotes tumorigenesis in the distal colon of ApcMin/+ mice.
Nicole M Sodir, Xuan Chen, Ryan Park, Andrea E Nickel, Peter S Conti, James R Bading

Cancer Res· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis